Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01075451 · ClinicalTrials.gov registry record
Antimicrobial Drug Use and Resistant Staphylococcus Aureus
A clinical trial, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- 41
- Enrollment target
NCT01075451: Completed study, sponsored by Virginia Commonwealth University.
NCT01075451 is a clinical trial that has completed, run by Virginia Commonwealth University. The registered enrollment target is 41 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01075451 has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- 41 participants
- Enrollment target
Study Summary
The purpose of this investigation is to study the relationships between antimicrobial stewardship program efforts, antimicrobial drug use, and infection control efforts to the incidence rates of hospital acquired infections with Staphylococcus aureus in a sample of US academic medical center hospitals.
Primary Outcome
Rates of hVISA and Staph.aureus with MIC creep to vancomycin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2010-01 |
| Est. Completion | 2013-05 |
What the finished NCT01075451 record still lists
NCT01075451 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 41 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01075451 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01075451 about?
NCT01075451 is a clinical study titled "Antimicrobial Drug Use and Resistant Staphylococcus Aureus". The purpose of this investigation is to study the relationships between antimicrobial stewardship program efforts, antimicrobial drug use, and infection control efforts to the incidence rates of hospital acquired infections with Staphylococcus aureus in a sample of US academic medical center hospita...
What is the current status of trial NCT01075451?
This trial is currently completed. The enrollment target is 41 participants. The study started on 2010-01. Estimated completion is 2013-05.
Who is sponsoring clinical trial NCT01075451?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia